Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. Export

@article{citeulike:5935581, abstract = {Objective: Our objective was to develop clinical practice guidelines for the diagnosis and treatment of patients with primary aldosteronism. Participants: The Task Force comprised a chair, selected by the Clinical Guidelines Subcommittee (CGS) of The Endocrine Society, six additional experts, one methodologist, and a medical writer. The Task Force received no corporate funding or remuneration. Evidence: Systematic reviews of available evidence were used to formulate the key treatment and prevention recommendations. We used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) group criteria to describe both the quality of evidence and the strength of recommendations. We used "recommend" for strong recommendations and "suggest" for weak recommendations.}, author = {Funder, John and Carey, Robert and Fardella, Carlos and Gomez-Sanchez, Celso and Mantero, Franco and Stowasser, Michael and Young, William and Montori, Victor M.}, citeulike-article-id = {5935581}, citeulike-linkout-0 = {http://dx.doi.org/10.1530/EJE-09-0870}, citeulike-linkout-1 = {http://view.ncbi.nlm.nih.gov/pubmed/19793760}, citeulike-linkout-2 = {http://www.hubmed.org/display.cgi?uids=19793760}, day = {30}, doi = {10.1530/EJE-09-0870}, issn = {1479-683X}, journal = {European journal of endocrinology / European Federation of Endocrine Societies}, keywords = {adrenal, aldosteronism}, month = {September}, posted-at = {2009-10-13 10:45:50}, priority = {2}, title = {Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline.}, url = {http://dx.doi.org/10.1530/EJE-09-0870}, year = {2009} }

TY - JOUR ID - citeulike:5935581 L3 - citeulike-article-id:5935581 N2 - Objective: Our objective was to develop clinical practice guidelines for the diagnosis and treatment of patients with primary aldosteronism. Participants: The Task Force comprised a chair, selected by the Clinical Guidelines Subcommittee (CGS) of The Endocrine Society, six additional experts, one methodologist, and a medical writer. The Task Force received no corporate funding or remuneration. Evidence: Systematic reviews of available evidence were used to formulate the key treatment and prevention recommendations. We used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) group criteria to describe both the quality of evidence and the strength of recommendations. We used "recommend" for strong recommendations and "suggest" for weak recommendations. JF - European journal of endocrinology / European Federation of Endocrine Societies SN - 1479-683X TI - Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. KW - adrenal KW - aldosteronism AU - Funder, John AU - Carey, Robert AU - Fardella, Carlos AU - Gomez-Sanchez, Celso AU - Mantero, Franco AU - Stowasser, Michael AU - Young, William AU - Montori, Victor PY - 2009/09/30/ UR - http://dx.doi.org/10.1530/EJE-09-0870 ER -